Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lilu Guo

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Molecular Therapy. Methods & Clinical Development|September 2, 2025
Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in miceKelly George, Raquel Riley, Shan Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
AAV gene therapy for GBA1-related diseasesSwathi Ayloo, Jae Cheon Ryu, Shih-Ching Chou, et al.
Nature Neuroscience|December 19, 2022
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationSean K Ryan, Matija Zelic, Yingnan Han, et al.
Communications Biology|August 2, 2024
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitroAgnes Cheong, Florin Craciun, Hervé Husson, et al.
The Journal of Clinical Investigation|June 19, 2025
Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophyShyam Ramachandran, Jeffery Ardinger, Jie Bu, et al.
Iscience|September 2, 2025
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophyJeremy Y Huang, Brian Freed, Martin Hanus, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Molecular Therapy. Methods & Clinical Development|September 2, 2025
Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in miceKelly George, Raquel Riley, Shan Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
AAV gene therapy for GBA1-related diseasesSwathi Ayloo, Jae Cheon Ryu, Shih-Ching Chou, et al.
Nature Neuroscience|December 19, 2022
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationSean K Ryan, Matija Zelic, Yingnan Han, et al.
Communications Biology|August 2, 2024
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitroAgnes Cheong, Florin Craciun, Hervé Husson, et al.
The Journal of Clinical Investigation|June 19, 2025
Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophyShyam Ramachandran, Jeffery Ardinger, Jie Bu, et al.
Iscience|September 2, 2025
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophyJeremy Y Huang, Brian Freed, Martin Hanus, et al.
Pageof 4